Evidence map›Paper›PMID 34649503›Full record

ArticleBMC infectious diseases2021

Values and preferences for hepatitis C self-testing among the general population and healthcare workers in Rwanda.

Janvier Serumondo, Sonjelle Shilton, Ladislas Nshimiyimana, Prosper Karame, Donatha Dushimiyimana, Emmanuel Fajardo, Eric Remera, Gallican N Rwibasira, Guillermo Z Martínez-Pérez

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Janvier SerumondoRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Sonjelle ShiltonFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland. sonjelle.shilton@finddx.org.
Ladislas NshimiyimanaRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Prosper KarameRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Donatha DushimiyimanaRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Emmanuel FajardoFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Eric RemeraRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Gallican N RwibasiraRwanda Biomedical Centre (RBC), Kigali, Rwanda.
Guillermo Z Martínez-PérezFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Rwanda Biomedical Center · RWFoundation for Innovative New Diagnostics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2018, Rwanda launched a 5-year hepatitis C virus (HCV) elimination plan as per the World Health Organization global targets to eliminate HCV by 2030. To improve awareness of HCV status, strategies are needed to ensure easy access to HCV testing by as-yet unreached populations. HCV-self-testing, an innovative strategy, could further increase HCV testing uptake. This assessment explores perceptions around HCV self-testing among members of the public and healthcare workers in Rwanda.

methodsA qualitative study was undertaken in Masaka District Hospital, comprising individual interviews, group interviews and participatory action research (PAR) activities. Purposive and snowball sampling methods guided the selection of informants. Informed consent was obtained from all participants. A thematic analysis approach was used to analyse the findings.

resultsThe participants comprised 36 members of the public and 36 healthcare workers. Informants appreciated HCV self-testing as an innovative means of increasing access to HCV testing, as well as an opportunity to test privately and subsequently autonomously decide whether to seek further HCV care. Informants further highlighted the need to make HCV self-testing services free of charge at the nearest health facility. Disadvantages identified included the lack of pre/post-test counselling, as well as the potential psychosocial harm which may result from the use of HCV self-testing.

conclusionHCV self-testing is perceived to be an acceptable method to increase HCV testing in Rwanda. Further research is needed to assess the impact of HCV self-testing on HCV cascade of care outcomes.

Indexed as

Hepatitis CSelf-TestingHealth PersonnelHumansRwandaUgandaHCV self-testQualitativeRwandaScreening

Identifiers

PMID34649503
PMCPMC8514804
OpenAlexW3206011547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.